Trial Profile
Phase I/II clinical trial of inactivated HVJ-E administration for advanced malignant melanoma patients
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 09 May 2017
Price :
$35
*
At a glance
- Drugs GEN 0101 (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 23 Nov 2011 New trial record